Customizing First Line Chemotherapy in Advanced Non-Small Cell Lung Cancer

NCT01356368 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER_GOV

Sponsor class

Stopped slow accrual rate

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: Cisplatin, Gemzar, Docetaxel, Alimta

Sponsor

National Guard Health Affairs